1 Answers

Chronic Lymphocytic Leukemia (CLL): Bendamustine is indicated for the treatment of patients with chronic lymphocytic leukemia. Efficacy relative to first line therapies other than chlorambucil has not been established.

Non-Hodgkin Lymphoma (NHL): Bendamustineis indicated for the treatment of patients with indolent B-cell non-Hodgkin lymphoma that has progressed during or within six months of treatment with rituximab or a rituximab-containing regimen.

Also indicated in Multiple myeloma.

Bendamax IV Infusion সম্পর্কে বিস্তারিত জেনে নিন এই লিঙ্ক থেকে Bendamax

3846 views